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Abstract Coagulation factor Va is an essential cofactor which combines with the serine protease factor Xa on a phospholipid surface to form the 
prothrombinase complex. In the present study, the structure of factor Va interacting with lipid surfaces containing phosphatidylserine was studied 
by electron microscopy. Two-dimensional crystals of factor Va were obtained on planar lipid films under quasi-physiological conditions. The 
two-dimensional projected structure of factor Va was calculated at a resolution of 2 nm, revealing dimers of factor Va arranged on the surface lattice 
with the symmetry of the plane group p2. Average unit cell dimensions are a = 14.4 nm, b = 8.8 nm, ~, = 107 °. Each factor Va molecule presents 
two distinct domains of protein density consisting of one small domain, of 3 nm in diameter, connected to a larger domain of about 6 nm x 4.5 nm. 
The projected structure of factor Va covers an area equivalent to about fifty phospholipid molecules. In addition, edge-on views of factor Va molecules 
bound to liposomes reveal a globular structure connected through athin stem to the liposome surface. A three-dimensional model of membrane-bound 
factor Va is proposed. 
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1. Introduction 
Factor Va, an essential constituent of the prothrombinase 
complex, is derived by a proteolytic leavage of factor V by 
thrombin [1,2]. The resulting factor Va product is a heterodimer 
composed of a heavy chain (Mr -- 105,000) and a light chain 
(Mr = 74,000) derived from the NH2-terminal and COOH-ter- 
minal ends of the factor V molecule, respectively. The two 
chains are non-covalently associated in the presence of divalent 
cations [2-5]. It is now well established that the interaction 
between factor Va and a lipid membrane requires the presence 
of negatively charged phospholipids [6,7] and is not dependent 
on the presence of exogenously added calcium ions [6]. A 
wealth of information concerning this interaction has been 
gathered by means of complementary biochemical and bio- 
physical approaches (review in [8]). However, a detailed struc- 
ture of membrane-bound factor Va has not been resolved. 
The specific interaction between factor Va and negatively 
charged lipids renders this system suitable for study by the 
lipid-layer two-dimensional (2D) crystallization technique [9]. 
This technique has already proven to be very powerful for 
structural studies of proteins interacting with membranes, ena- 
bling the resolution of their structure in the membrane-bound 
state [10-13]. In addition, this approach has the potential for 
high-resolution structure determination by electron crystallog- 
raphy [14] provided that well-ordered 2D crystals are obtained 
[15]. 
Here, we report the 2D crystallization of factor Va on planar 
lipid films consisting of a mixture of dioleoylphosphatidylserine 
(PS) and dioleoylphosphatidylcholine (PC). The projected 
structure of factor Va was resolved at a resolution of 2 nm. In 
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addition, binding of factor Va to liposomes provides comple- 
mentary edge-on views. We propose a three-dimensional (3D) 
model of human factor Va bound to a lipid membrane. 
2. Materials and methods 
2.1. Chemicals 
Phospholipids were purchased from Avanti-Polar Lipids (Alabaster, 
AL). N-octyl fl-o-glucopyranoside was from Sigma (St. Louis, MO). 
Other chemicals were of the best available commercial grade. 
2.2. Factor Va purification 
Human factor Va was a gift from Haematologic Technologies, lnc 
(Essex Junction, VT, USA) and was prepared as previously described 
[16,17]. 
2.3. 2D crystallization 
2D crystals of factor Va were prepared as described by Mosser et al. 
[10] in the case of annexin V. Crystallization experiments were carried 
out in teflon wells (4 mm in diameter, 1mm deep) filled with 17 gl of 
a 100 gg/ml factor Va solution in either buffer A (20 mM Tris-HC1, 150 
mM NaC1, 2 mM CaClz, 3 mM NAN3, pH 7.3) or buffer B (20 mM 
Tris-HCl, 150 mM NaCI, 3 mM ethylenediaminetetraacetic acid 
(EDTA), 3 mM NAN3, pH 7.3). A 0.6 gl drop of a 150 gM PS - 450 
gM PC lipid solution in chloroform/hexane (1:1, v/v) was deposited on 
top of the liquid surface with a microsyringe. Incubation was allowed 
for 12 h at room temperature. 
2.4. Liposome-bound factor Va 
Large unilamellar phospholipid vesicles were prepared by detergent 
dialysis [18] as follows. 250 gl of a 40 mg/ml PC solution in chloroform 
were mixed with 200gl ofa 5 mg/ml PS solution in chloroform, together 
with 275 gl of chloroform-solubilized N-octyl fl-D-glucopyranoside 
(20%, w/v). Chloroform was evaporated under reduced pressure. One 
ml of buffer made of 10 mM HEPES, 150 mM NaC1, 3 mM NaN 3, pH 
7.3 (buffer C) was added and the mixture was allowed to stand at room 
temperature for 1 h. The solution was poured into Spectra/Por no.1 
dialysis tubing (Medicell Int., London, UK) and dialyzed against buffer 
C at room temperature. Three bath changes were performed over two 
days. The liposomes were stored at 4°C until use. For binding experi- 
ments, 20/tl of factor Va at 360/.tg/ml in buffer A were mixed with 
4/11 of a liposome solution at 0.8 mg/ml total phospholipid content. 
This solution was incubated for 1 h at room temperature. In order to 
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separate liposome-bound factor Va from unbound protein, liposome 
suspensions were passed through a CL-4B Sepharose gel filtration 
column (molecular weight cut-off: 40 x 106 Daltons; 3.5 cm height, 0.7 
cm inner diameter) equilibrated and eluted with buffer A. 
2.5. Electron microscopy 
All electron microscopy (EM) observations were made by negative 
staining. In the case of factor Va 2D crystals, lipid films were picked 
up on carbon coated grids which had been deposited for 5 min on top 
of the incubating solution, carbon side facing the lipid film. The grids 
were washed with several drops of distilled water and negatively stained 
with 1% uranyl acetate (UA), pH 3.5, for 30 s. In the case of liposome- 
bound factor Va, a 5-/zl drop of a liposome-factor Va solution was 
adsorbed onto carbon-coated grids rendered hydrophilic by glow dis- 
charge in air under reduced pressure [19] and stained with 2% sodium 
phosphotungstate, pH 7.2, for 2 min. EM was carried out with a Philips 
CM12 electron microscope operating at 100 kV. Low-electron dose 
irradiation was used for imaging 2D crystals, while no special care was 
made to decrease the electron irradiation when imaging liposomes. 
Electron micrographs were recorded at 45,000 x magnification on 
Kodak SO163 films and developed under standard conditions. 
2.6. Image analysis 
The best crystalline areas were selected by optical diffraction a d 
digitized at the Sertit (Strasbourg, France) using a rotating drum mi- 
crodensitometer Wirth Dios (Frankfurt am Main, Germany) with step 
and spot sizes of 25 gm. Image processing was performed by standard 
methods [20] using an Imagic software system [21] extended with pro- 
grams of crystallographic analysis developed by V. Mallouh 
(L.G.M.E., Strasbourg). 
3. Results 
3.1. Factor Va 2D crystals 
2D crystals of factor Va were grown on planar lipid films 
made of PS and PC (1/3 molar ratio) when Ca 2÷ ions were 
present in the incubation buffer (buffer A, see section 2) (Fig. 
la). Factor Va 2D crystals presented a wide range of size and 
morphology, as commonly observed with other soluble pro- 
teins crystallized on lipid layers [22]. The best crystalline areas 
presented diffraction peaks arranged on an oblique lattice and 
extending up to a resolution of 2 nm (Fig. lb). The unit cell 
dimensions, defined by the geometry of  the reciprocal lattice, 
are: a = 14.4 _+ 0.7 nm, b = 8.8 _+ 0.4 nm, ~, = 107 -+ 2 °. Further 
analysis of the Fourier transform showed that phases were 
close to 0 ° and 180 °, indicating that the symmetry of the plane 
group is p2 [23]. 
When incubation was performed in the absence of Ca 2÷ 
(buffer B), 2D domains of protein-lipid complexes were 
observed which presented an overall aspect similar to those 
obtained in the presence of Ca 2+ (data not shown). However, 
none of these domains was of crystalline nature, under our 
experimental conditions. 
The 2D projected structure of factor Va was calculated at a 
resolution of 2 nm from the four best images (Fig. 2). Factor 
Va molecules are packed as dimers related by dyad axes normal 
to the crystal plane. Each factor Va molecule presents an asym- 
metrical distribution of protein density with overall dimensions 
8.5 nm x 6 nm. Two well-separated protein domains are re- 
solved within each factor Va molecule. One small domain (do- 
main 1 in Fig. 2), of high protein density, presents a circular 
shape of about 3 nm in diameter. The other domain (domain 
2) presents a uniform and lower density and has a rectangular 
shape of about 6 nm x 4.5 nm. It is noteworthy that for each 
processed image domain 1 consistently presented the highest 
density in the map, a feature which suggests the presence of an 
elongated structure viewed end-on. Domains 1 and 2 are con- 
nected through a short arm of low protein density, less than 
1 nm long. The closest distances beween monomers within a 
dimer, and thus the most likely contact areas, relate domain 1 
from one monomer to domain 2 from the other monomer. The 
surface covered by one factor Va molecule is about 34 nm 2. This 
surface is equivalent to about fifty lipid molecules, assuming an 
average lipid molecular surface of 0.7 nm 2. 
3.2. Liposome-bound factor Va 
We attempted to visualize factor Va molecules bound to 
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Fig. 1. (a) Electron image of an UA-negatively stained 2D crystal of factor Va. Faint stain striations extend over the entire area (this is better 
appreciated by viewing at glancing angle). Scale bar: 50 nm. (b) Distribution of Fourier transform amplitudes from a crystalline area (140x 140 nm2). 
Diffraction peaks are arranged onto an oblique lattice. The (4,2) reflection, at i/2.3 nm -~, has been encircled. Scale: 1 cm= 0.156 nm -t. 
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Fig. 2. 2D projection map of factor Va 2D crystals at 2 nm resolution. 
The map was calculated by Fourier synthesis after averaging the ampli- 
tudes from the four best images and imposing p2 symmetry to phases 
(mean phase residual: 19°). A unit cell has been outlined (a = 14.4 nm, 
b = 8.8 nm, y = 107 °) with p2 symmetry elements. Protein densities are 
represented with 4 contour levels (the increment between successive 
levels is equal to 1/4 th of the maximal value in the map). Stained areas 
are represented on a continuous grey scale. Domains 1 and 2 of one 
factor Va molecule are indicated. Scale bar: 5 rim. 
liposomes, in order to verify whether the dimeric organization 
of factor Va was a genuine feature or resulted from a favorable 
packing arrangement within the 2D crystals. Liposomes made 
of PS and PC, with a PC/PS molar ratio of 10, were used for 
these experiments. Cryo-EM observations [19] indicated that 
these liposomes were mostly unilamellar (data not shown). Li- 
posomes presenting a variety of staining patterns were observed 
(Fig. 3), illustrating a difficulty often encountered in imaging 
liposome structures by negative staining ([24]; M. Schmutz and 
A. Brisson, unpublished observations). Particles covering the 
liposome surface were mainly observed with liposome suspen- 
sions not submitted to gel filtration chromatography (Fig. 
3a,b). However, detailed molecular images could not be distin- 
guished, due to the high noise level induced by the presence of 
unbound protein. On the other hand, particles were clearly 
visible at the edges of liposomes exhibiting almost no stain 
deposited at their surface (Fig. 3c-f). These images provided 
views of membrane-bound factor Va molecules perpendicular 
to that of factor Va molecules in the 2D crystal. The main 
characteristic feature was the presence of protein densities 
aligned with a centre to centre distance of about 10 nm and 
separated from the liposome dge by a region filled with stain. 
The distance between the centre of mass of the protein density 
and the liposome dge was about 7 nm. Factor Va presented 
globular shapes with various aspects, due to the different rota- 
tional orientations of the molecules. The average size was 
6 nm× 5 nm, the largest dimension being parallel to the li- 
posome surface. A thin and elongated stem connecting the 
globular particle to the liposome surface was resolved in some 
images (arrows in Fig. 3/). These stems were most clearly re- 
solved in liposome suspensions submitted to gel filtration 
chromatography, although this treatment resulted in a displace- 
ment of most of liposome-bound factor Va molecules. 
3.3. Model of membrane-bound factor Va 
The two orthogonal projection views reported here were 
combined to produce a 3D model of membrane-bound factor 
Va (Fig. 4). Each factor Va molecule consists of two domains. 
Domain 1 exhibits acylindrical shape, 3 nm in diameter, which 
extends perpendicularly to the membrane plane over a distance 
of 10 nm. It is connected to a box-shaped domain 2 of dimen- 
sions 6 nm x 4.5 nm x 5 nm, positioned 4 nm from the mem- 
brane surface. 
4. Discussion 
The present study describes the structure of human factor Va 
interacting with lipid surfaces determined by electron micros- 
copy. The 2D projected structure of factor Va observed along 
a direction ormal to the membrane was determined by image 
analysis of 2D crystals. We found that factor Va molecules are 
arranged into dimers and present an asymmetrical distribution 
of protein density with two distinct domains (domains 1and 2 
in Fig. 2). In addition, complementary edge-on views of factor 
Va molecules bound to liposomes were obtained, allowing us 
to merge both projections into a 3D model. 
Several EM studies have concordantly revealed a multi-do- 
main structure for factor V [25-28], yet previous available 
structural data for factor Va were limited and the results were 
difficult to fit with a globular protein of Mr = 179,000. The 
main advantage of the present study is that 2D crystals were 
obtained, which enabled averaging over a large number of 
molecules observed along a single orientation. 
We postulate that domains 1 and 2 correspond to the factor 
Va light chain and heavy chain, respectively, for the following 
reasons: (1) the molecular masses calculated from the volumes 
of domains 1and 2 are 59,000 Da and 112,000 Da, respectively. 
These values are close to the known Mr of the subunits, 74,000 
and 105,000, respectively; (2) the fact that domain 1 consistently 
appears as a very dense structure l d us to assume that the stem 
connecting the globular core to the membrane was part of 
domain 1. This is in keeping with the fact that factor Va light 
chain is known to be responsible for the interaction with the 
lipid membrane [29-31]; (3) domains 1and 2 are well separated 
(Fig. 2), a feature which is consistent with the fact that the 
non-covalent association between both chains is mediated by 
Ca 2+ ions, and may not involve extensive contact areas as in 
classical oligomeric assemblies. 
It could not be unambiguously concluded from the 2D crys- 
tal analysis alone whether the repeating dimeric motif corre- 
sponded to one or two factor Va molecules. However, the latter 
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Fig. 3. Images of factor Va bound to (PS-PC) liposomes. (a,b) Liposomes densely covered with particles. No molecular details can be distinguished. 
In (b), a liposome devoid of particles presents a different staining aspect (4). (c,d,e,f) Liposomes exhibiting characteristic edge-on views of factor 
Va molecules. Alignments of factor Va molecules are visible (triangles). In (f), arrowheads point to thin stems connecting the main core of factor 
Va particles to the liposome dge. The liposome in (f) is from a suspension purified by gel filtration chromatography, explaining the lower background 
level. Scale bar: 50 nm. 
hypothesis i strongly supported by the morphological consid- 
erations developed above. In addition, the projected surface of 
a motif made of domains 1 and 2 covers an area equivalent to 
about 50 lipid molecules, which value is close to the value of 
42 lipid molecules determined at saturation for factor Va by 
Krishnaswamy and Mann [32]. Furthermore, no internal two- 
fold symmetry in the amino-acid sequence of factor Va has ever 
been postulated. The dimeric organization of factor Va could, 
however, simply be a result of ordered packing of molecules on 
the lipid surface under saturating conditions. Although at- 
tempts to visualize dimers on liposomes were unsuccessful, 
binding experiments showing a positive cooperativity with a 
Hill coefficient of 2 support he concept of factor Va dimeriza- 
tion [33]. 
The absence of 2D crystals noticed in the presence of EDTA 
deserves ome comments, as it is known that factor Va binds 
to PC/PS lipids independently of Ca 2÷, and that factor Va light 
chain binds independently of heavy chain [6,7]. A simple inter- 
pretation of EM results is that 2D crystals are stabilized by 
heavy chain-heavy chain or heavy chain-light chain interac- 
tions which can only occur when the factor Va heterodimer is 
intact. It is important to note that 2D domains were observed 
in the presence of EDTA, which indicates that factor Va light 
chain binds to the lipid film and in addition that factor Va light 
chains self-organize within 2D domains. The formation of 2D 
crystals constitutes an all-or-none process and requires that 
subtile parameters are found which enable the establishment of 
favorable interactions. Several studies have shown that binding 
of factor Va light chain to membranes involves both hydropho- 
bic and electrostatic nteractions [34-36]. Two regions of the 
factor Va light chain, located in the A3 domain and in the 
C1-C2 domains respectively, have further been identified as 
responsible of these two types of interaction [31]. Although the 
resolution of our analysis thus far is too limited for identifying 
domains within the molecule, our results uggest that these two 
regions are at a close distance, as the area covered by factor Va 
light chain corresponds to only ten lipid molecules. 
Fig. 4. Model of a molecule of factor Va bound to a PS-containing lipid 
monolayer. 
334 
A complete 3D description of factor Va is under progress, 
and the present approach will be extended to structural studies 
of complexes formed by factor Va and other protein members 
of the coagulation cascade. 
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